Awakn Announces The Findings From Phase II A/B Study Are To Be Published In American Journal Of Psychiatry
November 4, 2021
Ryan Allway November 4th, 2021 Worlds’s First Controlled Study To Investigate Ketamine-Assisted Psychotherapy TORONTO, CANADA, November 4, 2021 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat addiction, announced today that the ‘Ketamine in the Reduction of Alcoholic... Read more
Marijuana has for some time now remained one of the most important markets of the modern day. With so much legalization occurring in only the past few years, it seems as though cannabis use and know-how is very much on the rise. With the new industry that has been created, it seems as though there […]
The post Is Marijuana a Solution to Addiction? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
